Mesa Labs Q4 revenue down 5.6%, AOI down 21%; FY net income down 50% to $0.9M

MESA LABORATORIES INC /CO/

2023-FY EPS reported $0.17 revenue$219,080,000

Q4 revenues $55.6M, -5.6% YoY; net income $0.6M ($0.11 diluted EPS) vs net loss $1.8M prior year.
FY23 revenues $219.1M (+18.8%); core organic growth 5.2%; net income $0.9M ($0.17) -50.3% YoY.
AOI ex-unusual items Q4 $10.7M (-21.1% YoY); FY23 $45.8M (-1.7% YoY).
Clinical Genomics revenues -15.8% organic; Sema4 closure headwind ~$8.2M annually.
Management guides conservatively for FY24; sees soft CAPEX orders, expects currency headwinds to abate.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.